The agency also said that Medicare beneficiaries will for the first time be able to choose prescription drug plans that include broad sets of insulin priced at no more than $35 per month, per prescription.
Earlier this year, CMS launched its Part D senior savings model, which caps monthly insulin copays at $35. The agency predicts the program will save beneficiaries an average of $446 per year.
CMS said that Part D premiums have decreased by 12 percent since 2017, and enrollment has increased by 16.7 percent during the same time period.
Read CMS’ full news release here.
More articles on pharmacy:
Moderna’s coronavirus vaccine research alleged target of Chinese hackers
Operation Warp Speed: a timeline so far
25% of diabetes patients rationing treatments amid pandemic, survey finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.